arrow
M

Motohiro Ozone

Department of Neuropsychiatry
H指数:14
被引数:520

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

273. Serum cytokine levels in subjects at ultra-high risk for psychosis during the COVID-19 pandemic and their role in resilience: a multicenter study

273. 精神分裂症超高风险个体在COVID-19疫情期间的血清细胞因子水平及其在心理韧性中的作用:一项多中心研究

2026-09-090
OAAI
A 12-Week, Open-Label, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Lemborexant in Patients with Insomnia Comorbid with Depressive Episodes (SELENADE)

一项为期12周、开放标签、多中心试点研究,旨在评估莱莫雷沙坦在伴有抑郁发作的失眠患者中的有效性和安全性(SELENADE)。

2025-12-040
OAAI
Self-reported sleep variables, sleep quality, and quality of life assessment in transition to lemborexant in patients with Insomnia: the multicenter, open-label SOMNUS study

患者自报的睡眠变量、睡眠质量以及生活质量评估在转换为雷美雷酮治疗失眠过程中的应用:一项多中心、开放标签的SOMNUS研究

2025-10-010
OAAI
AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TREATMENT WITH LEMBOREXANT IN SUBJECTS WITH CHRONIC INSOMNIA (SOMNUS STUDY)

一项开放标签、多中心研究,旨在评估LEMBOREXANT治疗慢性失眠患者的有效性和安全性(SOMNUS研究)

2025-02-120
OA
Survey of psychiatric symptoms among inpatients with COVID-19 using the Diagnosis Procedure Combination data and medical records in Japan
2023-05-012
OAAI